A dose-response trial of once-daily diltiazem-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A dose-response trial of once-daily diltiazem

Published:1992-04 Issue:4 Volume:123 Page:1022-1026
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Felicetta James V.,Serfer Harry M.,Cutler Neal R.,Comstock Thomas J.,Huber Gary L.,Weir Matthew R.,Hafner Kerry,Park Glen D.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference8 articles.

1. A reappraisal of its pharmacological properties and therapeutic use;Buckley;Drugs,1990

2. Professional Use Information. CARDIZEM SR (diltiazem hydrochloride) Sustained Release Capsules. Marion Merrell Dow Inc., issued 1/89.

3. Use of a pharmacologic indicator to compare compliance with tablets prescribed to be taken once, twice, or three times daily;Pullar;Clin Pharmacol Ther,1988

4. How often is medication taken when prescribed? A novel assessment technique;Cramer;JAMA,1989

5. The 1988 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and toxicity of antihypertensive pharmacotherapy relative to effective dose 50;British Journal of Clinical Pharmacology;2019-08-19

2. Micro-porous surfaces in controlled drug delivery systems: design and evaluation of diltiazem hydrochloride controlled porosity osmotic pump using non-ionic surfactants as pore-former;Pharmaceutical Development and Technology;2013-06-13

3. Peripheral edema associated with calcium channel blockers: incidence and withdrawal rate – a meta-analysis of randomized trials;Journal of Hypertension;2011-07

4. Oral Controlled Release-Based Products for Life Cycle Management;Oral Controlled Release Formulation Design and Drug Delivery;2010-08-23

5. Clinical benefits versus shortcomings of diltiazem once-daily in the chronotherapy of cardiovascular diseases;Expert Opinion on Pharmacotherapy;2009-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3